Maryland Procurement Portal #BPM058087

Maryland Department of Health Seeks Actuarial Consulting for Hepatitis C Antiviral Coverage Policy

This opportunity involves the Maryland Department of Health - Administration, Boards & Commissions seeking actuarial consulting services related to Hepatitis C treatment coverage: - Government Buyer: - Maryland Department of Health - Administration, Boards & Commissions - Services Requested: - Actuarial consulting to evaluate and recommend strategies for limiting prior authorization requirements for direct-acting antiviral medications used in Hepatitis C treatment - Products/Part Numbers/Quantities: - No specific products, part numbers, or quantities are listed - OEMs and Vendors: - No OEMs or specific vendors are mentioned in the notice - Notable Requirements: - Focus on healthcare policy and pharmaceutical coverage - Expertise in actuarial analysis and recommendations for public health insurance programs - No attachments or additional documentation are provided

Description

This solicitation is for actuarial consulting services focused on limiting prior authorization for coverage of direct-acting antivirals used to treat Hepatitis C. The procurement is managed by the Department of Health - Administration, Boards & Commissions. The solicitation is currently open and will close on August 14, 2026. The primary contact for this opportunity is Andrea Allen, the procurement officer. No specific attachments or additional links are provided in the source.

View original listing